chr19-57398816-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001172773.2(ZNF548):c.565G>A(p.Glu189Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,613,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001172773.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF548 | NM_001172773.2 | c.565G>A | p.Glu189Lys | missense_variant | 4/4 | ENST00000336128.12 | NP_001166244.1 | |
ZNF548 | NM_152909.4 | c.529G>A | p.Glu177Lys | missense_variant | 3/3 | NP_690873.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF548 | ENST00000336128.12 | c.565G>A | p.Glu189Lys | missense_variant | 4/4 | 2 | NM_001172773.2 | ENSP00000337555.6 | ||
ENSG00000269533 | ENST00000596400.1 | c.51+4593G>A | intron_variant | 4 | ENSP00000472277.1 | |||||
ENSG00000268533 | ENST00000597410.1 | c.39+4593G>A | intron_variant | 3 | ENSP00000472152.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152184Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249066Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135118
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461708Hom.: 0 Cov.: 33 AF XY: 0.0000138 AC XY: 10AN XY: 727138
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152184Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 11, 2022 | The c.565G>A (p.E189K) alteration is located in exon 4 (coding exon 4) of the ZNF548 gene. This alteration results from a G to A substitution at nucleotide position 565, causing the glutamic acid (E) at amino acid position 189 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at